Phase 1b Study to Assess the Safety, Tolerability and Pharmacodynamics of PBFT02 in Adult Participants with Frontotemporal Dementia (FTD) and GRN or C9orf72 Mutations

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507724-23-00

Acronym

PBFT02-001

Enrollment

Registered

2023-10-11

Start date

2024-02-01

Completion date

Unknown

Last updated

2025-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

FRONTOTEMPORAL DEMENTIA (FTD)

None listed

Sex/Gender

All

Age

18 Years to No maximum

Portugal, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026